India, Sept. 26 -- United States President Donald Trump on Friday announced that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products from October 1 2025, a move likely to affect India. However, he introduced an exception - companies building production facilities in the United States will be exempt from the tariff.

In a post on Truth Social, Trump wrote, "Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be defined as 'breaking ground' and/or 'under construction.'"

However, news agency ANI quoted Sudarshan Jain, Secretary Gener...